ArticleBMJ open2025

Transtympanic sodium thiosulphate to prevent cisplatin-related hearing loss: a protocol for randomised controlled multicentre phase III trial, the SOUND trial.

Anouk V M Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.